Analytical Data
-
Gene name
PSMG2
- Application
-
Alternative Names
PSMG2;HCCA3;PAC2;TNFSF5IP1;Proteasome assembly chaperone 2
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q969U7
-
Expression Region
1-264aa
-
AA Sequence
MGSSHHHHHH SSGLVPRGSH MGSMFVPCGE SAPDLAGFTL LMPAVSVGNV GQLAMDLIIS TLNMSKIGYF YTDCLVPMVG NNPYATTEGN STELSINAEV YSLPSRKLVA LQLRSIFIKY KSKPFCEKLL SWVKSSGCAR VIVLSSSHSY QRNDLQLRST PFRYLLTPSM QKSVQNKIKS LNWEEMEKSR CIPEIDDSEF CIRIPGGGIT KTLYDESCSK EIQMAVLLKF VSEGDNIPDA LGLVEYLNEW LQILKPLSDD PTVSASRWKI PSSWRLLFGS GLPPALF
-
Molecular Weight
32 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
PSMG2, or Polypeptide Segment in Mitochondrial Genome 2, has garnered significant research interest due to its essential role in mitochondrial function and cellular metabolism. Mitochondria, often referred to as the powerhouse of the cell, are crucial for energy production through oxidative phosphorylation. PSMG2 has been implicated in various biological processes, including apoptosis, reactive oxygen species (ROS) regulation, and metabolic pathways. Mutations or dysregulation of PSMG2 have been associated with several diseases, including cancer and neurodegenerative disorders, making it a potential biomarker for disease progression and a target for therapeutic interventions. Understanding the structural and functional characteristics of PSMG2 is vital for elucidating its role in mitochondrial dynamics and cellular physiology. Recent advances in protein engineering and recombinant DNA technology have facilitated the production of PSMG2 in vitro, allowing researchers to study its interactions and effects on cellular processes. This research not only aims to pinpoint the mechanistic pathways involving PSMG2 but also seeks to explore its potential applications in drug development and gene therapy. As such, PSMG2 stands at the intersection of molecular biology and clinical research, holding promise for future advancements in the understanding and treatment of mitochondrial-related diseases.











